216571-38-9

Upstream product

• 170079-20-6 1,2-di-O-acetyl-5-O-benzoyl-3-deoxy-L-erythro-pentofuranose 
• 201287-86-7 Benzoic acid (2R,4S,5S)-4-acetoxy-5-(6-amino-purin-9-yl)-tetrahydro-furan-2-ylmethyl ester 
• 66224-66-6 adenine 

Downstream Products

• 216571-39-0 (2S,3R,5R)-2-[6-(Trityl-amino)-purin-9-yl]-5-trityloxymethyl-tetrahydro-furan-3-ol 
• 216571-41-4 [9-((2S,3S,5R)-3-Azido-5-trityloxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-trityl-amine 
• 216571-42-5 [9-((2S,3S,5R)-3-Amino-5-trityloxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-trityl-amine 
• 216571-40-3 [9-((2S,3S,5R)-3-Fluoro-5-trityloxymethyl-tetrahydro-furan-2-yl)-9H-purin-6-yl]-trityl-amine 

Relevant academic research and scientific papers

Unnatural β-L-enantiomers of nucleoside analogues as potent anti- hepatitis B virus agents

Several 2'- or 3'- substituted 2',3'-dideoxy-β-L-nucleosides bearing adenine as the base were stereospecifically synthesized and their antiviral properties examined. Two of them, namely 2'-azido- and 3'-azido-2',3'- dideoxy-β-L-adenosine (2'-N3